Nocdurna

Active Ingredient(s): Desmopressin Acetate
FDA Approved: * June 21, 2018
Pharm Company: * FERRING PHARMS INC
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Nocdurna Overview

Desmopressin, sold under the trade name DDAVP among others, is a medication used to treat diabetes insipidus, bedwetting, hemophilia A, von Willebrand disease, and high blood urea levels.[1] In hemophilia A and von Willebrand disease, it should only be used for mild to moderate cases.[1] It may be given in the nose, by injection into a vein, by mouth, or under the tongue.[1] Common side effects include headaches, diarrhea, and low blood sodium.&...

Read more Nocdurna Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Desmopressin

Recent Nocdurna Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Desmopressin Acetate
  • Injection: 0.004mg/ml, 0.015mg/ml, 4mcg/ml
  • Solution: 0.01%
  • Spray: 0.83mcg/0.1ml, 1.66mcg/0.1ml
  • Spray, Metered: 0.00083mg/spray, 0.00166mg/spray, 0.01mg/actuation, 0.01mg/spray, 0.15mg/spray, 1.5mg/spray, 150mcg/actuation
  • Tablet: 0.0277mg, 0.0553mg, 0.1mg, 0.2mg, 27.7mcg, 53.3mcg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Nocdurna: (2 results)

Sorted by National Drug Code
  • 55566-5050 Nocdurna 27.7 ug/1 Sublingual Tablet by Ferring Pharmaceuticals Inc.
  • 55566-5070 Nocdurna 55.3 ug/1 Sublingual Tablet by Ferring Pharmaceuticals Inc.

Other drugs which contain Desmopressin Acetate or a similar ingredient: (7 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 25 September 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 501 S. Cherry St, Suite 1100, Denver, CO, 80246, USA